Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tipranavir/Ritonavir PK Effects on NRTI/NNRTI in HIV-1
NCT02251223Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2001
- Primary completion
- Feb 2002
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tipranavir in human immunodeficiency virus infection (HIV), sponsored by Boehringer Ingelheim. Started Feb 2001; status: completed.
02
Drugs
tipranavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02251223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02251223.